Abstract
Hemolytic uremic syndrome (HUS) is a thrombotic microvascular disease, characterized by microvascular hemolytic anemia (red blood cell debris can be found), thrombocytopenia, and renal function damage. Micro thrombus mainly distributed in the kidney. Key factors for the pathogenesis includes infection, toxins, anti-endothelial cell antibodies, and drugs. In recent years, new recognition has been made for the causes and pathogenesis of HUS, and plasma infusion and plasmapheresis have been the most effective methods for treatment of HUS, greatly improving the survival rate of HUS patients. Key words: Hemolytic uremic syndrome; Child; Diagnosis; Treatment
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
